Singapore-headquartered digital health and data analytics company Holmusk signed a Memorandum of Understanding (MoU) with Janssen (China) Research & Development Centre (Janssen), to explore the development of a digital mental health strategy in China.

Based on the MoU, Holmusk and Janssen propose to focus on generating insights from real-world data on depression and other mental health disorders to develop novel, scalable solutions to address the increasing burden of disease in China. The two organisations would also identify areas of unmet need that a digital platform can enhance, and define the supporting, prioritised functionality based on the Janssen Neuroscience portfolio in China. 

Holmusk’s experience in digital therapeutics and deep analytics will be used to develop and implement a competitive, comprehensive solution for mental health in China, with an initial focus on depression. The combination of Holmusk’s mental health platform and Janssen’s expertise and network will be used to inform future, targeted management of wellness-oriented consumers, as well as mental health patients.

THE LARGER TREND

Mental health tools are a hot field in digital health. In fact, in a recent Nature Digital Medicine study, researchers found 1,435 mental health apps available in the app stores. However, mental health issues are still a relatively taboo topic to address especially in Asia, so the use of digital tools and platforms can help alleviate the increasing burden of mental health conditions.

Earlier this week, Oxford VR launched a first-of-kind VR-enabled mental health treatment solution in Hong Kong, through a partnership with AXA HK and the Chinese University of Hong Kong (CUHK).

ON THE RECORD 

“We are excited to work with Janssen, an organization trusted by patients and customers, to develop much-needed solutions for people battling mental health diseases,” said Nawal Roy, Founder and CEO of Holmusk in a statement.